藥碼
MIT03
藥名
化療 Mitomycin C 不保存 10 mg/Vial
英文商品名
化療 Mitonco 不保存 10 mg/Vial
中文商品名
密多邁杏凍晶注射劑
螢幕名
化療 Mitonco 不保存 10 mg/Vial
劑型
Inj
規格
Mitomycin 10mg/vial
成分
藥理分類
健保碼
BC28315229
ATC碼
藥品圖片
外觀圖片
適應症
#高警訊藥品

胃癌、胰臟癌
Gastric cancer:
Treatment of disseminated adenocarcinoma of the stomach (in combination with other chemotherapy agents) and as palliative treatment when other modalities have failed.
Pancreatic cancer:
Treatment of disseminated adenocarcinoma of the pancreas (in combination with other chemotherapy agents) and as palliative treatment when other modalities have failed.
* Limitations of use: Not recommended for single-agent primary therapy or to replace appropriate surgery and/or radiotherapy in the treatment of these conditions.
藥理
Antineoplastic agents, DNA alkylator
Mitomycin alkylates DNA to produce DNA cross-linking (primarily with guanine and cytosine pairs) and inhibits DNA and RNA synthesis. Mitomycin is not cell cycle specific but has its maximum effect against cells in late G and early S phases.
藥動學
1. Metabolism: Primarily hepatic
2. Half-life elimination: 17 minutes (30 mg dose)
3. Excretion: Feces; Urine
禁忌症
1. Hypersensitivity to mitomycin or any component of the formulation
2. Thrombocytopenia; Coagulation disorders,or other increased bleeding tendency
懷孕分類
Adverse events have been observed in animal reproduction studies.
哺乳分類
1.It is not known if mitomycin is present in breast milk.
2.Due to the potential for serious adverse reactions in the breastfed infant, breastfeeding is not recommended by the manufacturer.
副作用
Common:
1. Gastrointestinal: Anorexia, nausea, vomiting
2. Hematologic & oncologic: Bone marrow depression, hemolytic-uremic syndrome, thrombotic thrombocytopenic purpura
3. Miscellaneous: Fever
Postmarketing:
Adult respiratory distress syndrome (ARDS), bladder spasm, cardiac failure, dyspnea, extravasation reactions, hepatic sinusoidal obstruction syndrome, interstitial fibrosis, malaise, nonproductive cough, pulmonary infiltrates, renal failure, skin rash, weakness
劑量和給藥方法
IV 20mg/m2 Q6~8W
小兒調整劑量
Refer to adult dosing.
腎功能調整劑量
1. CrCl <10 mL/minute: Reduce dose to 75% of usual dose.
2. Continuous ambulatory peritoneal dialysis (CAPD): Reduce dose to 75% of usual dose.
肝功能調整劑量
There are no dosage adjustments provided in the manufacturer's labeling (has not been studied).
安定性
store in 15-25℃
藥袋資訊
臨床用途
化學治療藥
主要副作用
噁心、嘔吐、食慾差、毛髮稀疏等
泡製方法
儲存方式
請置於 15-30℃ 乾燥處儲存
注意事項
其他說明
化療藥局 化4 | 藥庫 化療
藥品外觀
顏色
形狀
剝痕
標記1
標記2
其他
健保藥價
640
自費價
851.2
仿單
資料庫
健保給付規定